DavosPharma is a leading provider of discovery services and custom cGMP manufacturing of APIs, NCEs, and Biologics through carefully vetted global partners.  Since 1972, we have been integrating drug discovery R&D with commercialization. 

 

DavosPharma is able to provide regulatory support, program management, and supply chain management with complete transparency.  We have been instrumental in more than 20 API/NCE global product launches, including:  Viracept, Sustiva, Tarceva, and Rimadyl.

 

DavosPharma has the in-house expertise to work with you on a specific service or across an entire commercialization process.  We strive to be a seamless extension of your team.  Contact our office for more detailed information.